Axoft is developing a soft, implantable brain computer interface (BCI) that will integrate with brain tissue and provide a more natural and long-term solution for neurological conditions.


  • Cambridge, MA
  • Seed (Oct 2022)
    • $8M (including “nonequity assistance in May 2023)
  • Why I like it
    • Axoft represents the type of huge leap in biomedical innovation that gets me excited about the future. Their approach skips the traditional plodding development pathway and opens up new possibilities for treating neurological conditions in a novel way. Axoft’s founding team includes researchers from leading research communities and is just the right stage in which having an active and supportive board structure could accelerate the opportunity.

Want to Learn More about AXOFT?

Reach out below!